# A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping

> **NCT02209532** · NA · COMPLETED · sponsor: **Novadaq Technologies ULC, now a part of Stryker** · enrollment: 180 (actual)

## Conditions studied

- Endometrial Cancer
- Uterine Cancer
- Cervical Cancer

## Interventions

- **DEVICE:** PINPOINT

## Key facts

- **NCT ID:** NCT02209532
- **Lead sponsor:** Novadaq Technologies ULC, now a part of Stryker
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2019-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02209532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02209532, "A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02209532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*